FDA to Decide on First mRNA Flu Vaccine

The FDA is expected to rule on approving the first mRNA-based flu vaccine. If approved, it could provide more effective and rapidly adaptable protection than traditional flu shots. This decision would expand mRNA technology beyond COVID-19 into routine influenza prevention.

Sources (2)